These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 27173875)

  • 21. MDM2 promoter SNP309 is associated with an increased susceptibility to chronic lymphocytic leukemia and correlates with MDM2 mRNA expression in Chinese patients with CLL.
    Dong HJ; Fang C; Fan L; Zhu DX; Wang DM; Zhu HY; Zhuang Y; Miao KR; Liu P; Xu W; Li JY
    Int J Cancer; 2012 May; 130(9):2054-61. PubMed ID: 21647873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1).
    Möhle R; Failenschmid C; Bautz F; Kanz L
    Leukemia; 1999 Dec; 13(12):1954-9. PubMed ID: 10602415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elucidating the CXCL12/CXCR4 signaling network in chronic lymphocytic leukemia through phosphoproteomics analysis.
    O'Hayre M; Salanga CL; Kipps TJ; Messmer D; Dorrestein PC; Handel TM
    PLoS One; 2010 Jul; 5(7):e11716. PubMed ID: 20661426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphisms and haplotypes in multidrug resistance 1 gene are not associated with chronic lymphocytic leukemia susceptibility and prognostic parameters of chronic lymphocytic leukemia in Chinese population.
    Dong HJ; Miao KR; Qiao C; Zhuang Y; Shen WY; Hong M; Fan L; Liu P; Xu W; Li JY
    Leuk Lymphoma; 2011 Jun; 52(6):1003-9. PubMed ID: 21463115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. JAK2 tyrosine kinase mediates integrin activation induced by CXCL12 in B-cell chronic lymphocytic leukemia.
    Montresor A; Toffali L; Mirenda M; Rigo A; Vinante F; Laudanna C
    Oncotarget; 2015 Oct; 6(33):34245-57. PubMed ID: 26413812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CXCR4 and CD74 together enhance cell survival in response to macrophage migration-inhibitory factor in chronic lymphocytic leukemia.
    Thavayogarajah T; Sinitski D; El Bounkari O; Torres-Garcia L; Lewinsky H; Harjung A; Chen HR; Panse J; Vankann L; Shachar I; Bernhagen J; Koschmieder S
    Exp Hematol; 2022 Nov; 115():30-43. PubMed ID: 36096455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis.
    Penna G; Allegra A; Alonci A; Aguennouz M; Garufi A; Cannavò A; Gerace D; Alibrandi A; Musolino C
    Med Oncol; 2011 Dec; 28(4):1549-54. PubMed ID: 20496015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD1d expression as a prognostic marker for chronic lymphocytic leukemia.
    Anastasiadis A; Kotsianidis I; Papadopoulos V; Spanoudakis E; Margaritis D; Christoforidou A; Gouliamtzi S; Tsatalas C
    Leuk Lymphoma; 2014 Feb; 55(2):320-5. PubMed ID: 23668820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia.
    Deaglio S; Vaisitti T; Aydin S; Ferrero E; Malavasi F
    Blood; 2006 Aug; 108(4):1135-44. PubMed ID: 16621959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential.
    Deaglio S; Vaisitti T; Aydin S; Bergui L; D'Arena G; Bonello L; Omedé P; Scatolini M; Jaksic O; Chiorino G; Efremov D; Malavasi F
    Blood; 2007 Dec; 110(12):4012-21. PubMed ID: 17699742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel association between CD74 polymorphisms and hematologic toxicity in patients with NSCLC after platinum-based chemotherapy.
    Tan X; Wu Q; Cai Y; Zhao X; Wang S; Gao Z; Yang Y; Li X; Qian J; Wang J; Su B; Chen H; Han B; Jiang G; Lu D
    Clin Lung Cancer; 2014 Jan; 15(1):67-78.e12. PubMed ID: 24220096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The -137G/C Polymorphism in Interleukin-18 Gene Promoter Contributes to Chronic Lymphocytic and Chronic Myelogenous Leukemia Risk in Turkish Patients.
    Yalçın S; Mutlu P; Çetin T; Sarper M; Özgür G; Avcu F
    Turk J Haematol; 2015 Dec; 32(4):311-6. PubMed ID: 26376814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD38 gene polymorphism and chronic lymphocytic leukemia: a role in transformation to Richter syndrome?
    Aydin S; Rossi D; Bergui L; D'Arena G; Ferrero E; Bonello L; Omedé P; Novero D; Morabito F; Carbone A; Gaidano G; Malavasi F; Deaglio S
    Blood; 2008 Jun; 111(12):5646-53. PubMed ID: 18424664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The expression of sphingosine-1 phosphate receptor-1 in chronic lymphocytic leukemia cells is impaired by tumor microenvironmental signals and enhanced by piceatannol and R406.
    Borge M; Remes Lenicov F; Nannini PR; de los Ríos Alicandú MM; Podaza E; Ceballos A; Fernández Grecco H; Cabrejo M; Bezares RF; Morande PE; Oppezzo P; Giordano M; Gamberale R
    J Immunol; 2014 Sep; 193(6):3165-74. PubMed ID: 25127862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SDF-1/CXCL12 and CXCR4 gene variants, and elevated serum SDF-1 levels are associated with preeclampsia.
    Karakus S; Bagci B; Bagci G; Sancakdar E; Yildiz C; Akkar O; Cetin A
    Hypertens Pregnancy; 2017 May; 36(2):124-130. PubMed ID: 28001450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CXCL12 rs1801157 polymorphism in patients with breast cancer, Hodgkin's lymphoma, and non-Hodgkin's lymphoma.
    de Oliveira KB; Oda JM; Voltarelli JC; Nasser TF; Ono MA; Fujita TC; Matsuo T; Watanabe MA
    J Clin Lab Anal; 2009; 23(6):387-93. PubMed ID: 19927352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1.
    Burger JA; Tsukada N; Burger M; Zvaifler NJ; Dell'Aquila M; Kipps TJ
    Blood; 2000 Oct; 96(8):2655-63. PubMed ID: 11023495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different frequencies and effects of ABCB1 T3435C polymorphism on clinical and laboratory features of B cell chronic lymphocytic leukemia in Kurdish patients.
    Maroofi F; Amini S; Roshani D; Ghaderi B; Abdi M
    Tumour Biol; 2015 Apr; 36(4):2863-8. PubMed ID: 25586345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The SDF-1 G > A polymorphism at position 801 plays no role in multiple myeloma but may contribute to an inferior cause-specific survival in chronic lymphocytic leukemia.
    Pemberton NC; Paneesha S; Hiller L; Starczynski J; Hooper L; Pepper C; Pratt G; Fegan C
    Leuk Lymphoma; 2006 Jul; 47(7):1239-44. PubMed ID: 16923552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Q192R and L55M Polymorphisms of Paraoxonase 1 Gene in Chronic Myelogenous Leukemia and Chronic Lymphocytic Leukemia.
    Tomatir AG; Pehlivan S; Sahin HH; Balci SO; Budeyri S; Pehlivan M
    Anticancer Res; 2015 Sep; 35(9):4807-12. PubMed ID: 26254371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.